The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-Benzyloxy-2-diphenylacetyl-6-methoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid ID: ALA155836
Cas Number: 152362-51-1
PubChem CID: 9892451
Max Phase: Preclinical
Molecular Formula: C32H29NO5
Molecular Weight: 507.59
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2c(c1OCc1ccccc1)CC(C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2
Standard InChI: InChI=1S/C32H29NO5/c1-37-28-18-17-25-20-33(31(34)29(23-13-7-3-8-14-23)24-15-9-4-10-16-24)27(32(35)36)19-26(25)30(28)38-21-22-11-5-2-6-12-22/h2-18,27,29H,19-21H2,1H3,(H,35,36)
Standard InChI Key: GHBCIXGRCZIPNQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
6.0000 -2.9167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7042 -3.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0000 -2.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5750 -2.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2792 -3.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8625 -1.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2875 -1.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5667 -2.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7000 -4.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7125 -1.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8625 -0.8500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4167 -2.9250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1542 -2.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8625 -3.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7167 -0.8542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4125 -4.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9792 -4.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1542 -2.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8625 -0.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4250 -2.1042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4375 -1.6792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1500 0.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4042 -5.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2750 -4.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9792 -5.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1167 -4.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7250 -2.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1500 1.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4417 -0.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2667 -5.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8292 -4.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1125 -5.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -4.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7250 0.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4375 1.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7167 1.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -5.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8292 -5.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 8 2 0
5 1 1 0
6 4 1 0
7 3 1 0
8 5 1 0
9 2 1 0
10 3 1 0
11 6 1 0
12 2 2 0
13 18 1 0
14 8 1 0
15 10 2 0
16 9 1 0
17 9 1 0
18 14 2 0
19 11 1 0
20 10 1 0
21 13 1 0
22 19 1 0
23 16 2 0
24 17 2 0
25 17 1 0
26 16 1 0
27 21 1 0
28 22 2 0
29 22 1 0
30 25 2 0
31 26 2 0
32 23 1 0
33 24 1 0
34 29 2 0
35 28 1 0
36 34 1 0
37 30 1 0
38 31 1 0
7 4 1 0
13 6 2 0
37 33 2 0
38 32 2 0
36 35 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 507.59Molecular Weight (Monoisotopic): 507.2046AlogP: 5.44#Rotatable Bonds: 8Polar Surface Area: 76.07Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.70CX Basic pKa: ┄CX LogP: 5.79CX LogD: 2.49Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.34Np Likeness Score: -0.17
References 1. Klutchko S, Hamby JM, Hodges JC. (1994) Tetrahydroisoquinoline derivatives with AT2-specific angiotensin II reception binding inhibitory activity, 4 (1): [10.1016/S0960-894X(01)81122-7 ] 2. Klutchko S, Hamby JM, Hodges JC. (1994) Tetrahydroisoquinoline derivatives with AT2-specific angiotensin II reception binding inhibitory activity, 4 (1): [10.1016/S0960-894X(01)81122-7 ] 3. Juillerat-Jeanneret L.. (2020) The Other Angiotensin II Receptor: AT2R as a Therapeutic Target., 63 (5): [PMID:32030982 ] [10.1021/acs.jmedchem.9b01780 ] 4. Wannberg J,Gising J,Lindman J,Salander J,Gutiérrez-de-Terán H,Ablahad H,Hamid S,Grönbladh A,Spizzo I,Gaspari TA,Widdop RE,Hallberg A,Backlund M,Leśniak A,Hallberg M,Larhed M. (2021) N-(Methyloxycarbonyl)thiophene sulfonamides as high affinity AT2 receptor ligands., 29 [PMID:33309749 ] [10.1016/j.bmc.2020.115859 ]